Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

419 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Chronic trial results

Recruiting

Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS

NCT05636514

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Concord Repatriation and General Hospital Sydney, New South Wales, Australia
  • Nepean Hospital Sydney, New South Wales, Australia
View Trial Details
Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424

Conditions
AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Stanford Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details
Recruiting

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

NCT06994676

Conditions
AML - Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Medical Center Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Medicine Chicago, Illinois, United States
View Trial Details
Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

NCT06950034

Conditions
Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), +24 more
Locations
  • Stanford University Stanford, California, United States
  • Moffitt Tampa, Florida, United States
  • DFCI Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)

NCT06647862

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • China-Japan Friendship Hospita Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • First Hospital of Lanzhou University Lanzhou, Gansu, China
View all 43 locations
View Trial Details
Recruiting

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03850574

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Irvine Irvine, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
View all 34 locations
View Trial Details

Related conditions